Afrezza

Nisha K. Patel, Pharm.D., Ana Emiliano, M.D., Brian Pinto, Pharm.D.

INDICATIONS

FDA

  • Approved for use as a rapid-acting insulin to be given at the start of meals in adult patients with diabetes mellitus

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: June 2, 2019